Changes of upper gastrointestinal symptoms and endoscopic findings in Japan over 25 years

Internal Medicine

Volumn 50, Issue 13, 2011, Pages 1357-1363

  Manabe, Noriaki ^a   Haruma, Ken ^a   Kamada, Tomoari ^a   Kusunoki, Hiroaki ^a   Inoue, Kazuhiko ^a   Murao, Takahisa ^a   Imamura, Hiroshi ^a   Matsumoto, Hiroshi ^a   Tarumi, Ken Ichi ^a   Shiotani, Akiko ^a   Hata, Jiro ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Dyspepsia; Endoscopy; Gastro esophageal reflux disease; Gastrointestinal symptom; Heartburn; Peptic ulcer

Indexed keywords

ADULT; ARTICLE; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL PAIN; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PEPTIC ULCER; PREVALENCE; REFLUX ESOPHAGITIS; UPPER GASTROINTESTINAL TRACT;

ADULT; AGED; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; UPPER GASTROINTESTINAL TRACT;

EID: 79960059845     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4731     Document Type: Article

References (32)

1. Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region. J Dig Dis 8: 179-185, 2007.
2. El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 43: 327-333, 1998.
3. Wong SN, Sollano JD, Chan MM, et al. Changing trends in peptic ulcer prevalence in a tertiary care setting in the Phillippines: a seven-year study. J Gastroenterol Hepatol 20: 628-632, 2005.
4. Fujimoto K. Prevalence and epidemiology of gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther 20(Suppl 8): 5-8, 2004.
5. Furukawa N, Iwakiri R, Koyama T, et al. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by en-doscopy. J Gastroenterol 34: 441-444, 1999.
6. Veldhuyzen van Zanten SJ, Flook N, Chiba N, et al. An evidence based approach to the management of patients with dyspepsia in the era of Helicobacter pylori. CMAJ 162: S3-S23, 2000.
7. Talley NJ, Silverstein MD, Agreus L, Nyren O, Sonnenberg A, Holtmann G. AGA technical review: Evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 114: 582-595, 1998.
8. Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig Dis Sci 40: 584-589, 1995.
9. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survery of functional gastrointestinal disorders. Prevalence, sociodemogra-phy, and health impact. Dig Dis Sci 38: 1569-1580, 1993.
10. Heikkinen M, Pikkarainen P, Takala J, Räsänen H, Julkunen R. Etiology of dyspepsia: four hundred unselected consecutive patients in general practice. Scand J Gastroenterol 30: 519-523, 1995.
11. Kagevi I, Lofstedt S, Persson LG. Endoscopic findings and diagnoses in unselected dyspeptic patients at a primary health care center. Scand J Gastroenterol 24: 145-150, 1989.
12. Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Over-the-counter availability of potent ulcer drugs. Study of changes in the drug use pattern and the pressure on diagnostic measures. Ugeskr Laeger 153: 1405-1410, 1991.
13. Moayyedi P, Zilles A, Clough M, Hemingbrough E, Chalmers DM, Axon AT. The effectiveness of screening and treating Helico-bacter pylori in the management of dyspepsia. Eur J Gastroenterol Hepatol 11: 1245-1250, 1999.
14. Ladabaum U, Chey WD, Scheiman JM, Fendrick AM. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: cost-minimization analysis. Aliment Pharmacol Ther 16: 1491-1501, 2002.
15. Bowrey DJ, Griffin SM, Wayman J, Karat D, Hayes N, Raimes SA. Use of alarm symptoms to select dyspeptic for endoscopy causes patients with curable esophagogastric cancer to be overlooked. Surg Endosc 20: 1725-1728, 2006.
16. Barenys M, Abad A, Pons JM, et al. Scoring system has better discriminative value than Helicobacter pylori testing in patients with dyspepsia in a setting with high prevalence of infection. Eur J Gastroenterol Hepatol 12: 1275-1282, 2000.
17. Hassan C, Bersani G, Buri L, et al. Appropriateness of upper-GI endoscopy: an Italian survey on behalf of the Italian Society of Digestive Endoscopy. Gastrointest Endosc 65: 767-774, 2007.
18. van Kerkhoven LA, van Rijswijck SJ, van Rossum LG, et al. Is there any association between referral indications for open-access upper gastrointestinal endoscopy and endoscopic findings? Endo-scopy 39: 502-506, 2007.
19. Mishima I, Adachi K, Arima N, et al. Prevalence of endoscopi-cally negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol 40: 1005-1009, 2005.
20. Fujisawa T, Kumagai T, Akamatsu T, Kiyosawa K, Matsunaga Y. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroen-terol 94: 2094-2099, 1999.
21. Haruma K, Okamoto S, Kawaguchi H, et al. Reduced incidence of Helicobacter pylori infection in young Japanese persons between the 1970s and the 1990s. J Clin Gastroenterol 25: 583-586, 1997.
22. Koike T, Ohara S, Sekine H, et al. Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis. Aliment Pharmacol Ther 15: 813-820, 2001.
23. Manabe N, Yoshihara M, Sasaki A, Tanaka S, Haruma K, Chayama K. Clinical characteristics and natural history of patients with low-grade reflux esophagitis. J Gastroenterol Hepatol 17: 949-954, 2002.
24. Ho KY, Chan YH, Kang JY. Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country. Am J Gastroenterol 100: 1923-1928, 2005.
25. Loffeld RJ. H. pylori and reflux esophagitis in Turkish patients living in the Zaanstreek region in the Netherlands. Dig Dis Sci 48: 1846-1849, 2003.
26. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and risk for gastroesophageal reflux dosease and its complications. Ann Intern Med 143: 199-211, 2005.
27. Goh KL. Obesity and increasing gastroesophageal reflux disease in Asia. J Gastroenterol Hepatol 22: 1557-1558, 2007.
28. Nishikawa K, Sugiyama T, Kato M, et al. Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese populations. Eur J Gastroenterol Hepatol 12: 635-640, 2000.
29. Ong TZ, Hawkey CJ, Ho KY. Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study. J Clin Gastroenterol 40: 795-800, 2006.
30. Haruma K, Sumii K, Uemura N, et al. Epidemiologic studies and recent changes of peptic ulcer disease during the past 10 years: study of 2548 cases collected during 1974 to 1983 in Hiroshima University Hospital. Hiroshima J Med Sci 35: 201-215, 1986.
31. Kawai K, Shirakawa K, Misaki F, Hayashi K, Watanabe Y. Natural history and epidemiologic studies of peptic ulcer disease in Japan. Gastroenterology 96: 581-585, 1989.
32. Goh KL, Wong HT, Lim CH, Rosaida MS. Time trends in peptic ulcer, erosive reflux oesophagitis, gastric and oesophageal cancers in a multiracial Asian population. Aliment Pharmacol Ther 29: 774-780, 2009.